文献速递生殖医学

在生育照护中采用预后模型实施针对性期待管理:一项多层面策略的整群随机试验

Implementing targeted expectant management in fertility care using prognostic modelling: a cluster randomized trial with a multifaceted strategy.
PubMed 文献 · Hum Reprod · 2017-01-01

该整群随机对照试验在荷兰25家诊所比较多层面实施策略与常规照护对原因不明不孕夫妇期待管理指南依从性的影响。干预组依从性从49%升至69%(OR 2.66;95%CI 1.45-4.89),对照组从49%升至61%(OR 2.03;95%CI 1.38-3.00),校正后差异8%未达统计学显著(OR 1.31;95%CI 0.67-2.59)。干预组与对照组6个月内持续妊娠率无显著差异(25% vs 27%;OR 0.72;95%CI 0.40-1.27)。

要点

  • 多层面实施策略未显著提高对期待管理指南推荐的依从性(OR 1.31;95%CI 0.67-2.59)。
  • 干预组依从性从49%升至69%,对照组从49%升至61%,两组均有改善。
  • 6个月内持续妊娠率干预组25% vs 对照组27%,无显著差异。

核心结论

  • 与常规照护相比,多层面实施策略未显著增加对原因不明不孕夫妇期待管理指南推荐的依从性。
  • 干预组与对照组6个月内持续妊娠率无显著差异。

研究设计与样本

  • 在荷兰25家诊所开展的整群随机对照试验,于2013年3月至2014年5月进行。
  • 诊所随机分为实施策略组(干预组,n=13)与常规照护组(对照组,n=12)。
  • 基线纳入544对夫妇,效果测量时纳入485对(干预组247对/对照组238对)。
  • 数据收集为回顾性,来源于病历研究和患者问卷。

主要发现

  • 干预组指南依从性从49%升至69%(OR 2.66;95%CI 1.45-4.89)。
  • 对照组指南依从性从49%升至61%(OR 2.03;95%CI 1.38-3.00)。
  • 病例组合校正的多层分析显示,8%的差异未达统计学显著(OR 1.31;95%CI 0.67-2.59)。
  • 生育检查后6个月内持续妊娠率干预组25% vs 对照组27%(OR 0.72;95%CI 0.40-1.27),无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 可能存在选择偏倚,纳入研究的夫妇社会经济地位高于无应答者,其对指南依从性的影响尚不明确。
  • 研究进行功效计算时未考虑对照组依从性的意外改善。
  • 将结果推广至其他有期待管理推荐的国家可能存疑,因为其他国家对期待管理的障碍可能差异很大。
  • 干预组依从性改善率变异较大,值得通过过程评价进一步分析各诊所的实施过程以及专业人员与夫妇对该策略的接触和体验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the effectiveness of a multifaceted implementation strategy compared to usual care on improving the adherence to guideline recommendations on expectant management for couples with unexplained infertility? SUMMARY ANSWER: The multifaceted implementation strategy did not significantly increase adherence to guideline recommendations on expectant management compared to care as usual. WHAT IS KNOWN ALREADY: Intrauterine insemination (IUI) with or without ovarian hyperstimulation has no beneficial effect compared to no treatment for 6 months after the fertility work-up for couples with unexplained infertility and a good prognosis of natural conception. Therefore, various professionals and policy makers have advocated the use of prognostic profiles and expectant management in guideline recommendations. STUDY DESIGN, SIZE, DURATION: A cluster randomized controlled trial in 25 clinics in the Netherlands was conducted between March 2013 and May 2014. Clinics were randomized between the implementation strategy (intervention, n = 13) and care as usual (control, n = 12). The effect of the implementation strategy was evaluated by comparing baseline and effect measurement data. Data collection was retrospective and obtained from medical record research and a patient questionnaire. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 544 couples were included at baseline and 485 at the effect measurement (247 intervention group/238 control group). MAIN RESULTS AND THE ROLE OF CHANCE: Guideline adherence increased from 49 to 69% (OR 2.66; 95% CI 1.45-4.89) in the intervention group, and from 49 to 61% (OR 2.03; 95% CI 1.38-3.00) in the control group. Multilevel analysis with case-mix adjustment showed that the difference of 8% was not statistically significant (OR 1.31; 95% CI 0.67-2.59). The ongoing pregnancy rate within six months after fertility work-up did not significantly differ between intervention and control group (25% versus 27%: OR 0.72; 95% CI 0.40-1.27). LIMITATIONS REASONS FOR CAUTION: There is a possible selection bias, couples included in the study had a higher socio-economic status than non-responders. How this affects guideline adherence is unclear. Furthermore, when powering for this study we did not take into account the unexpected improvement of adherence in the control group. WIDER IMPLICATIONS OF THE FINDINGS: Generalization of our results to other countries with recommendations on expectant management might be questionable because barriers for expectant management can be very different in other countries. Furthermore, due to a large variation in improved adherence rate in the intervention group it will be interesting to further analyse the process of implementation in each clinic with a process evaluation on professionals and couples' exposure to and experiences with the strategy. STUDY FUNDING/COMPETING INTEREST(S): Supported by Netherlands Organisation for Health Research and Development (ZonMW, project number 171203005). No competing interests. TRIAL REGISTRATION NUMBER: Dutch trial Register, www.trialregister.nl NTR3405. TRIAL REGISTRATION DATE: 19 April 2012. DATE OF FIRST PATIENT'S ENROLMENT: 10 July 2012.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kersten FAM, Nelen WLDM, van den Boogaard NM, et al. Implementing targeted expectant management in fertility care using prognostic modelling: a cluster randomized trial with a multifaceted strategy. Hum Reprod. 2017. PMID: 28591847. doi:10.1093/humrep/dex213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。